Chemotherapy MOA Flashcards

1
Q

Gemcitabine
MOA
excretion
side effect common after infusion
Rare bad S/E (4)

A

Antimetabolite (pyrimidine)
renal
fever, flu-like symptoms
Capillary leak syndrome, HUS/TTP, PRES, pneumonitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Abraxane what is it and what are the side effect differences
dose adj

A

nab-paclitaxel, protein-bound taxol (stabilizes microtubules)
hepatic adjustments, no renal
compared to taxol, abraxane has:
Less: hypersensitivity reactions, neutropenia
More: neuropathy, nausea, diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5-Fluorouracil
specific MOA
metabolism
specific derm SE
overdose symptoms
rare bad SE (1)
Check med list and avoid this drug

Avoid concurrent use of this drug

A

Anti-metabolite (thymidylate synthetase inhibitor)
hepatic avoid in severe impairment but no renal dose adj even on HD
hand and foot syndrome
cytopenias, mucositis, diarrhea
Cardiac ischemia
Avoid with warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Oxaliplatin
MOA
dose adjust
Bad SE (5)

A

Alkylating platinum agent
Renal dose adjustment (no hepatic dose adj)
Allergic reactions at any time
Cold sensitivity/neuropathy
Immune-mediated TCP
PRES
Pneumonitis
Hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Irinotecan
MOA
metabolism/excretion
lab cut-off contraindication
infusion side effects and treatment
main SE (1)

A

Topoisomerase I inhibitor
liver
bilirubin >2 contraindicated
Cholinergic syndrome- pre-treated with atropine
Diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Eribulin
Moa
Se

A

Microtubule destabilizing
Neutropenia, neuropathy, Qtc prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Docetaxel
moa
metabolism
lab cut-off contraindication
cause of the allergic reaction
premed needed and why

A

Microtubule stabilizer
hepatic
contraindicated with elevated bilirubin (above normal)
Mixed in castor oil which people can react to
dexamethasone ppx for fluid retention/capillary leak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Paclitaxel
MOA
metabolism
specific cardiac side effect
allergy risk

A

Microtubule stabilizer
liver (no renal adj)
bradycardia
cremophor-based allergy, strong premed need

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If pt forgot steroid premedication

A

Increase dexametasone in infusion to 20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cabazitaxel
Use

A

Can be still used if taxane resistant
Not docetaxel candidate
Needs growth factor due to prolonged nadir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Paclitaxel allergic reaction cause and symptoms

A

cremophor, slow infusion trial to see if improvement, redness, flushing, rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

methotrexate MOA and excretion

A

antimetabolite
Dihydrofolate reductase

renal excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

topotecan MOA specific #, excretion

A

topo I, renal excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ifosfamide MOA, excretion, toxicity and the byproduct cause and sister drug given with it and why

A

alkylating agent, hepatic and renal,

acrolein induced hemorrhagic cystitis and chloroacetaldehyde nephrotoxicity and neurotoxicity

mesna

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cetuximab
MOA
common SE
cause of allergy and what do you switch to
electrolyte issue

A

chimeric human/mouse IgG1 monoclonal antibody against EGFR
rash
mouse part of antibody –> switch to panitumumab (humanized anti EGFR)
magnesium low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

cardiac toxicity in 5-FU is associated with bolus or infusion

A

infusion, could consider trial of bolus in rechallenge

17
Q

5-FU toxicity genetic issue
gene
symptoms of the toxicity

A

DPD deficiency
mucositis, pancytopenia, diarrhea

18
Q

leucovorin when used with 5-FU goal

A

enhances 5-FU inhibition of thymidylate synthase

19
Q

po morphine equivalent for iv morphine

A

3 (take IV morphine and multiply by 3 for po)

20
Q

tramadol po to morphine po

A

1/10 (take po tramadol and divide by 10 for po morphine)

21
Q

dilaudid po to morphine po

A

4 (take po dilaudid and multiply by 4 to get po morphine)

22
Q

oxycodone to morphine po

A

2 (take oxy and mutiply by 2 to get po morphine)

23
Q

vedolizumab
use
moa

A

grade 3-4 autoimmune colitis refractory to steroids
integrin antagoinst to block migration of T cells to the gut

24
Q

infliximab
use
avoid in which scenario
moa

A

grade 3-4 autoimmune colitis refractory to steroids
avoid with autoimmune hepatitis
TNFa inhibitor

25
gene related to topoisomerase toxicity symptoms
UGT1A1 diarrhea predominant
26
Drugs associated with radiation recall (5)
Doxorubicin, docetaxel, paclitaxel, gemcitabine, capecitabine
27
Vincristine/vinblastine/vinorelbine MOA metabolism side effect to tell patients about (4) what happens if given intrathecally
Microtubule destabilization hepatic alopecia, constipation with prophylactic bowel reg, bronchospasm/pulm tox, needs port (vesicant) paralysis and death if IT
28
bevacizumab specific MOA dose adj? bad SE (5)
VEGF-A inhibitor no dose adj with liver or kidney dysfunction nephrotic syndrome, bowel perforation, thrombotic events including MI/stroke, PRES
29
ariprepitant MOA avoid with this chemo drug
antiemetic that antagonizes substance P/neurokinin 1 (NK1) ifosfamide due to CYP3A4 overlap
30
ondansetron, granisetron, palonosetron MOA
serotonin-5-HT3 antagonists (hydroxytryptamine)
31
proclorperazine MOA
D2 dopamine receptor and cholinergic receptors
32
high emetogenic drugs definition antiemetic treatment examples
>90% emesis risk 4 drug regimen with zofran, aprepitant, steroid, olanzapine AC doxorubicin >60 cisplatin ifosfamide melphalan sacituzumab govitecan carbo AUC >4 cyclophosphamide >1500
33
vandetanib use MOA cardiac SE
medullary thyroid cancer EGFR inhibitor Qtc prolongation
34
everolimus MOA lab to monitor side effect to tell patients
mtor inhibitor lipids mouth sores requiring steroid mouthwash
35
ixabepilone use moa
breast cancer metastatic single agent (TNBC or HR+HER2-) microtubule stabilizer hepatically cleared think about docetaxel, paclitaxel similar class
36
Pemetrexed dose adj MOA specific supportive meds bad SE (3)
antimetabolite that distrupts folate metabolic processes via inhibition of multiple targets in the pathway (TS, DHFR, FARFT, AICARFT)--> purine and thymidine nucleotide synthesis inhibition dose adj for renal, use not recommended with crcl <45 folic acid, b12 injections SJS/TEN, nephrotoxicity, pulmonary toxicity
37
Lenvatinib MOA SE bad (11)
Multi TKI QTc prolongation, hemorrhage, fistula, hepatotoxicty, renal toxicity/proteinuria, hypocalcemia, hypothyroidism, hyperthyroidism, PRES, thrombotic events, poor wound healing (hold for a week before and after surgery)